JP2009524014A5 - - Google Patents

Download PDF

Info

Publication number
JP2009524014A5
JP2009524014A5 JP2008549934A JP2008549934A JP2009524014A5 JP 2009524014 A5 JP2009524014 A5 JP 2009524014A5 JP 2008549934 A JP2008549934 A JP 2008549934A JP 2008549934 A JP2008549934 A JP 2008549934A JP 2009524014 A5 JP2009524014 A5 JP 2009524014A5
Authority
JP
Japan
Prior art keywords
stnfαr1
subject
mmp
level
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008549934A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009524014A (ja
Filing date
Publication date
Priority claimed from GBGB0600916.1A external-priority patent/GB0600916D0/en
Application filed filed Critical
Publication of JP2009524014A publication Critical patent/JP2009524014A/ja
Publication of JP2009524014A5 publication Critical patent/JP2009524014A5/ja
Pending legal-status Critical Current

Links

JP2008549934A 2006-01-17 2007-01-17 子癇前症の検出及び予測 Pending JP2009524014A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0600916.1A GB0600916D0 (en) 2006-01-17 2006-01-17 detecting and predicting pre-eclampsia
PCT/GB2007/000123 WO2007083099A1 (en) 2006-01-17 2007-01-17 Detecting and predicting pre-eclampsia

Publications (2)

Publication Number Publication Date
JP2009524014A JP2009524014A (ja) 2009-06-25
JP2009524014A5 true JP2009524014A5 (cg-RX-API-DMAC7.html) 2010-02-25

Family

ID=35998177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008549934A Pending JP2009524014A (ja) 2006-01-17 2007-01-17 子癇前症の検出及び予測

Country Status (10)

Country Link
US (1) US7638287B2 (cg-RX-API-DMAC7.html)
EP (1) EP1974220B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009524014A (cg-RX-API-DMAC7.html)
AT (1) ATE504002T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007206756B2 (cg-RX-API-DMAC7.html)
CA (1) CA2602681C (cg-RX-API-DMAC7.html)
DE (1) DE602007013524D1 (cg-RX-API-DMAC7.html)
ES (1) ES2364314T3 (cg-RX-API-DMAC7.html)
GB (1) GB0600916D0 (cg-RX-API-DMAC7.html)
WO (1) WO2007083099A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
WO2009094665A1 (en) * 2008-01-25 2009-07-30 Perkinelmer Health Sciences, Inc. Methods for determining the risk of prenatal complications
US20110294227A1 (en) * 2008-11-20 2011-12-01 Perkinelmer Health Sciences, Inc. Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers
WO2010091253A1 (en) 2009-02-06 2010-08-12 Women & Infants' Hospital Of Rhode Island Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
HRP20150802T1 (xx) * 2010-03-24 2015-11-06 Preelumina Diagnostics Ab Hbf i a1m kao markeri za rano otkrivanje preeklampsije
AU2012351504C1 (en) * 2011-12-15 2018-04-26 Mycartis N.V. Biomarkers and parameters for preeclampsia
US20150157276A1 (en) * 2012-04-24 2015-06-11 Siemens Healthcare Diagnostics Inc. Pre-eclampsia screening methods
EP2954324B1 (en) * 2013-02-08 2019-07-31 University of Iowa Research Foundation Method using copeptin to predict onset of preeclampsia
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
PL3189336T3 (pl) 2014-09-02 2019-07-31 Wallac Oy Sposób określania ryzyka stanu przedrzucawkowego
FR3037657B1 (fr) * 2015-06-22 2017-06-23 Univ Rouen Centre Hospitalier Methode de diagnostic des troubles causes par l'alcoolisation foetale
WO2019099998A1 (en) * 2017-11-17 2019-05-23 University Of Washington Connected system for information-enhanced test results
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECLAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR TESTS
WO2022173786A1 (en) * 2021-02-10 2022-08-18 Mirvie, Inc. Methods and systems for conducting pregnancy-related clinical trials
FR3157091A1 (fr) * 2023-12-26 2025-06-27 Universite De Montpellier Prédiction du comportement biomécanique de la paroi artérielle à travers l’analyse temporelle du signal oscillométrique au cours de la mesure de pression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028006A1 (en) 1996-12-23 1998-07-02 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
GB0026823D0 (en) 2000-11-02 2000-12-20 King S College London Diagnosis of pre-eclampsia
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
ES2556164T3 (es) * 2003-09-23 2016-01-13 The General Hospital Corporation Cribado de la preeclampsia
CA2485722A1 (en) * 2003-10-22 2005-04-22 Paul Lehmann Soluble transferrin receptor

Similar Documents

Publication Publication Date Title
JP2009524014A5 (cg-RX-API-DMAC7.html)
CN104749384B (zh) 确定母体健康风险的方法
Castera Noninvasive assessment of liver fibrosis
CA2602681C (en) Detecting and predicting pre-eclampsia
Zhang et al. Defining normal and abnormal fetal growth: promises and challenges
Rigau et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage
BRPI0501917A8 (pt) Dispositivo para determinar um parâmetro hemodinâmico de um paciente por meio de análise de perfil de pulsação
ATE438860T1 (de) P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
CN106796241B (zh) 确定先兆子痫风险的方法
Jan et al. Diagnostic accuracy of spot urinary protein/creatinine ratio for proteinurea in pregnancy induced hypertension
Skupski et al. Preoperative predictors of death in twin-to-twin transfusion syndrome treated with laser ablation of placental anastomoses
Hale et al. Pulse pressure and arterial compliance prior to pregnancy and the development of complicated hypertension during pregnancy
Mello et al. Individual longitudinal patterns in biochemical and hematological markers for the early prediction of pre-eclampsia
JP2006524325A5 (cg-RX-API-DMAC7.html)
Prefumo et al. Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
WO2021085425A1 (ja) 血管老化予測方法、疾患リスク予測方法、血管老化予測用バイオマーカー、疾患用バイオマーカー、測定キット、及び、診断装置
Kamat et al. Serial estimation of flow mediated dilatation in women at risk of hypertensive disorders of pregnancy
RU2299006C2 (ru) Способ диагностики артериальной гипертензии, вызванной беременностью
RU2581710C2 (ru) Способ диагностики портальной гипертензии при хронических диффузных заболеваниях печени
Dobrowolski et al. Longitudinal changes in maternal left atrial volume index and uterine artery pulsatility indices in uncomplicated pregnancy
Wilkinson et al. Commentary: birthweight arterial stiffness and blood pressure: in search of a unifying hypothesis
RU2007132384A (ru) Способ прогнозирования и диагностики гиперфибринолиза
RU2239354C1 (ru) Способ прогнозирования риска возникновения гипо- и гиперволемических нарушений в различные сроки гестации